Skip to main content

Advertisement

Log in

Cardioprotective effects of glycyrrhizic acid involve inhibition of calcium influx via L-type calcium channels and myocardial contraction in rats

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Glycyrrhizic acid (GA) is one of the main active components in licorice and has often been reported to have cardioprotective effects. However, the underlying cellular mechanisms remain unclear. The aim of this study is to verify the protective effects of GA against isoproterenol (ISO)-induced myocardial ischemia injury in rats. Another aim is to explore the cellular mechanisms based on the L-type Ca2+ channel, myocardial cell contraction, and intracellular Ca2+ ([Ca2+]i) transient. The results show that GA reduced the ST segment elevation, decreased the heart rate, prevented ISO-induced QT-interval shortening, improved heart morphology, and decreased the activity of CK and LDH. GA blocked ICa-L in a dose-dependent manner. The concentration for 50% of the maximal effect (EC50) of GA was 145.54 μg/mL, and the maximal inhibition was 47.43 ± 0.75% at 1000 μg/mL. However, GA did not affect the dynamical properties of the Ca2+ channel. GA reversibly reduced the amplitude of cell contraction in a dose-dependent manner and slowed down its deflection and recovery, as well as the [Ca2+]i transient. The data demonstrate that GA inhibits L-type Ca2+ channels, decreases the [Ca2+]i transient, and shows a negative cardiac inotropic effect in the ventricular myocardial cells of adult rats. It also protects the myocardia from ischemia injury induced by ISO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Author contribution statement

LC and SG conceived and designed the research. ML, YX, and ZW conducted the experiments. ML, ZW, and ZM analyzed the data. XH interpreted the data. ML wrote the manuscript. DM and SS searched the literature. SS collected funds. All authors read and approved the manuscript.

Funding

This work was supported by the Department of Education of Hebei Province (Nos. ZD2018038 and ZD2016091) and the State Administration of Traditional Chinese Medicine of the People’s Republic of China (Nos. 2019075 and 2019135).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shengjiang Guan, Shijiang Sun or Li Chu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Ethical approval

All programs involving animals in this study were in accordance with the Guidelines of Animal Experiments of the Committee of Medical Ethics, the Declaration of Helsinki principles, and the Ministry of Health of China. All experimental animal handling procedures were approved by the Ethics Committee for Animal Experiments of Hebei University of Chinese Medicine (approval number: DWLL2018004; approval date: August 6, 2018).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, M., Wen, Z., Xue, Y. et al. Cardioprotective effects of glycyrrhizic acid involve inhibition of calcium influx via L-type calcium channels and myocardial contraction in rats. Naunyn-Schmiedeberg's Arch Pharmacol 393, 979–989 (2020). https://doi.org/10.1007/s00210-019-01767-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-019-01767-3

Keywords

Navigation